BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 31711499)

  • 1. Cost-effectiveness of the SLIMMER diabetes prevention intervention in Dutch primary health care: economic evaluation from a randomised controlled trial.
    Duijzer G; Bukman AJ; Meints-Groenveld A; Haveman-Nies A; Jansen SC; Heinrich J; Hiddink GJ; Feskens EJM; de Wit GA
    BMC Health Serv Res; 2019 Nov; 19(1):824. PubMed ID: 31711499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLIMMER: a randomised controlled trial of diabetes prevention in Dutch primary health care: design and methods for process, effect, and economic evaluation.
    Duijzer G; Haveman-Nies A; Jansen SC; ter Beek J; Hiddink GJ; Feskens EJ
    BMC Public Health; 2014 Jun; 14():602. PubMed ID: 24928217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let's Prevent Diabetes cluster-randomised controlled trial.
    Leal J; Ahrabian D; Davies MJ; Gray LJ; Khunti K; Yates T; Gray AM
    BMJ Open; 2017 Jan; 7(1):e013592. PubMed ID: 28069625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of a lifestyle intervention in primary care to prevent type 2 diabetes mellitus and cardiovascular diseases: a randomized controlled trial.
    van Wier MF; Lakerveld J; Bot SD; Chinapaw MJ; Nijpels G; van Tulder MW
    BMC Fam Pract; 2013 Apr; 14():45. PubMed ID: 23557482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of involving nurse specialists for adult patients with urinary incontinence in primary care compared to care-as-usual: an economic evaluation alongside a pragmatic randomized controlled trial.
    Albers-Heitner CP; Joore MA; Winkens RA; Lagro-Janssen AL; Severens JL; Berghmans LC
    Neurourol Urodyn; 2012 Apr; 31(4):526-34. PubMed ID: 22275126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of systematic fast-track transition from oncological treatment to specialised palliative care at home for patients and their caregivers: the DOMUS trial.
    Halling CMB; Wolf RT; Sjøgren P; Von Der Maase H; Timm H; Johansen C; Kjellberg J
    BMC Palliat Care; 2020 Sep; 19(1):142. PubMed ID: 32933489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes Prevention Program.
    Sathish T; Oldenburg B; Thankappan KR; Absetz P; Shaw JE; Tapp RJ; Zimmet PZ; Balachandran S; Shetty SS; Aziz Z; Mahal A
    BMC Med; 2020 Sep; 18(1):251. PubMed ID: 32883279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial.
    Henderson C; Knapp M; Fernández JL; Beecham J; Hirani SP; Cartwright M; Rixon L; Beynon M; Rogers A; Bower P; Doll H; Fitzpatrick R; Steventon A; Bardsley M; Hendy J; Newman SP;
    BMJ; 2013 Mar; 346():f1035. PubMed ID: 23520339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis for a tele-based health coaching program for chronic disease in primary care.
    Oksman E; Linna M; Hörhammer I; Lammintakanen J; Talja M
    BMC Health Serv Res; 2017 Feb; 17(1):138. PubMed ID: 28202032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review.
    Zhou X; Siegel KR; Ng BP; Jawanda S; Proia KK; Zhang X; Albright AL; Zhang P
    Diabetes Care; 2020 Jul; 43(7):1593-1616. PubMed ID: 33534726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Process evaluation of a randomised controlled trial of a diabetes prevention intervention in Dutch primary health care: the SLIMMER study.
    van Dongen EJ; Duijzer G; Jansen SC; Ter Beek J; Huijg JM; Leerlooijer JN; Hiddink GJ; Feskens EJ; Haveman-Nies A
    Public Health Nutr; 2016 Nov; 19(16):3027-3038. PubMed ID: 27256153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complaint-Directed Mini-Interventions for Depressive Symptoms: A Health Economic Evaluation of Unguided Web-Based Self-Help Interventions Based on a Randomized Controlled Trial.
    Wijnen BF; Lokman S; Leone S; Evers SM; Smit F
    J Med Internet Res; 2018 Oct; 20(10):e10455. PubMed ID: 30274958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2003 Sep; 26(9):2518-23. PubMed ID: 12941712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of a lifestyle intervention in preventing Type 2 diabetes.
    Irvine L; Barton GR; Gasper AV; Murray N; Clark A; Scarpello T; Sampson M
    Int J Technol Assess Health Care; 2011 Oct; 27(4):275-82. PubMed ID: 22004767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Facilitated Access to a Self-Management Website, Compared to Usual Care, for Patients With Type 2 Diabetes (HeLP-Diabetes): Randomized Controlled Trial.
    Li J; Parrott S; Sweeting M; Farmer A; Ross J; Dack C; Pal K; Yardley L; Barnard M; Hudda M; Alkhaldi G; Murray E
    J Med Internet Res; 2018 Jun; 20(6):e201. PubMed ID: 29884608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program.
    Neumann A; Lindholm L; Norberg M; Schoffer O; Klug SJ; Norström F
    Eur J Health Econ; 2017 Sep; 18(7):905-919. PubMed ID: 27913943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of guideline-based stepped and collaborative care versus treatment as usual for patients with depression - a cluster-randomized trial.
    Brettschneider C; Heddaeus D; Steinmann M; Härter M; Watzke B; König HH
    BMC Psychiatry; 2020 Aug; 20(1):427. PubMed ID: 32859177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
    Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
    Trials; 2015 Nov; 16():496. PubMed ID: 26530718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
    Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
    BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A guided and unguided internet- and mobile-based intervention for chronic pain: health economic evaluation alongside a randomised controlled trial.
    Paganini S; Lin J; Kählke F; Buntrock C; Leiding D; Ebert DD; Baumeister H
    BMJ Open; 2019 Apr; 9(4):e023390. PubMed ID: 30967405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.